Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic

被引:0
|
作者
Liegeon, Geoffroy [1 ]
Kaperak, Christopher [1 ]
Friedman, Eleanor E. [1 ]
Djuricich, Paul [2 ]
Dawdani, Alicia [1 ]
Stafford, Kane [2 ]
Plotkin, Sophie [1 ]
Schmitt, Jessica [1 ]
Hazra, Aniruddha [1 ]
Christopoulos, Katerina A. [3 ]
Schneider, John A. [1 ]
Mcnulty, Moira C. [1 ]
机构
[1] Univ Chicago, Dept Med, Chicago, IL USA
[2] Univ Chicago, Dept Pharm, Chicago, IL USA
[3] Univ Calif San Francisco, Div HIV ID & Global Med, San Francisco, CA USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2025年 / 12卷 / 03期
基金
美国国家卫生研究院;
关键词
cabotegravir; injectable; long-acting; people with HIV; rilpivirine; PROGRAM; CARE;
D O I
10.1093/ofid/ofaf094
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe referrals and uptake of long-acting injectable cabotegravir/rilpivirine at an academic clinic in Chicago. In a pharmacy-led model, 118 (18%) people with HIV were referred and 78 (12%) initiated long-acting injectable cabotegravir/rilpivirine from 1 January 2021 to 31 May 2023. Implementation, especially for people with HIV who were not virally suppressed, requires further support for patients, providers, and clinic systems.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida
    Fisk-Hoffman, Rebecca J.
    Ranger, Sashaun S.
    Gracy, Abigail
    Gracy, Hannah
    Manavalan, Preeti
    Widmeyer, Maya
    Leeman, Robert F.
    Cook, Robert L.
    Canidate, Shantrel
    AIDS PATIENT CARE AND STDS, 2024, 38 (06) : 275 - 285
  • [42] The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
    Phillips, Andrew N.
    Bansi-Matharu, Loveleen
    Cambiano, Valentina
    Ehrenkranz, Peter
    Serenata, Celicia
    Venter, Francois
    Pett, Sarah
    Flexner, Charles
    Jahn, Andreas
    Revill, Paul
    Garnett, Geoff P.
    LANCET GLOBAL HEALTH, 2021, 9 (05): : E620 - E627
  • [43] Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth Analysis
    van Welzen, Berend J.
    Van Lelyveld, Steven F. L.
    Ter Beest, Gerjanne
    Gisolf, Jet H.
    Geerlings, Suzanne E.
    Prins, Jan M.
    Van Twillert, Gitte
    Van Nieuwkoop, Cees
    Van der Valk, Marc
    Burger, David
    Wensing, Annemarie M. J.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (01) : 189 - 195
  • [44] Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities
    Llibre, Josep M.
    Kuritzkes, Daniel A. R.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (09) : 1655 - 1657
  • [45] Cabotegravir: The first long-acting injectable for HIV pre-exposure prophylaxis
    Prather, Caitlin
    Jeon, Chaeok
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (21) : 1898 - 1905
  • [46] Long-acting injectable cabotegravir for PrEP: A game-changer in HIV prevention?
    Liegeon, Geoffroy
    Ghosn, Jade
    HIV MEDICINE, 2023, 24 (06) : 653 - 663
  • [47] Long-acting rilpivirine for HIV prevention
    Jackson, Akil
    McGowan, Ian
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 253 - 257
  • [48] Long-acting cabotegravir/rilpivirine as a safe antiretroviral therapy in solid organ transplanted HIV patients
    Moreno, Ana
    Del Campo, Santos
    Jesus Perez-Elias, Maria
    Luis Casado, Jose
    Garcia, Miguel
    Velez, Manuel
    Jesus Vivancos, Maria
    Moreno, Santiago
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 82 - 82
  • [49] Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice
    Borghetti, Alberto
    Farinacci, Damiano
    Ciccullo, Arturo
    Dusina, Alex
    Moschese, Davide
    Iannone, Valentina
    D'Angelillo, Anna
    Lombardi, Francesca
    Delle Donne, Valentina
    Massaroni, Valentina
    Visconti, Elena
    Tamburrini, Enrica
    Di Giambenedetto, Simona
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4970 - 4974
  • [50] HIV virologic response and baseline genotypic resistance in a long-acting cabotegravir/rilpivirine initiation program
    Masich, Anne M.
    Gomes, Denese
    Higginson, Robert T.
    Morgan, Zara
    Nixon, Daniel
    Tran, Melissa
    Winthrop, Elizabeth
    Fulco, Patricia P.
    AIDS, 2023, 37 (10) : 1641 - 1642